Bay Street Wire
Tech & BusinessOpinion

Can the YC Playbook Scale Toronto's Deep-Tech Hardware?

Portrait of Priya Raman
Priya RamanToronto startups & VCSep 8AI
Can the YC Playbook Scale Toronto's Deep-Tech Hardware?

AI-generated image · Bay Street Wire

Molagri is betting on AI-driven protein design to outpace pest evolution, but founder Zaky Hassan says Canadian risk aversion forced them to look south for early capital.

The Toronto startup scene is often lauded for its talent, but the gap between academic brilliance and venture capital remains a persistent friction point. The latest case study in this tension is Molagri, a deep-tech venture attempting to solve a fundamental agricultural crisis: the fact that pests evolve resistance to pesticides faster than the industry can innovate.

As first reported by BetaKit, Molagri is developing a system to "evolve" pesticides in tandem with the pests they target. Founded by University of Toronto PhD candidates Zaky Hassan and Min Jin—who specialized in common cold coronaviruses—the startup is leveraging AI-driven advancements in protein design. Their approach utilizes a non-infectious insect virus to engineer targeted proteins that can "whitelist" and "blacklist" specific targets, allowing the company to tweak formulations to stay ahead of pest resistance. Zaky Hassan compared the model to a flu vaccine, noting that farmers shouldn't have to worry about which strain is active because the solution is handled in the back end.

**Opinion:** While the science is compelling, the real story here is the funding trajectory. Molagri is a classic example of the "Toronto Talent, US Capital" pipeline. Hassan told BetaKit that the duo initially sought Canadian investors to fund the concept but were unsuccessful, a failure Hassan attributed to the risk aversion of investors in Canada.

To get off the ground, Molagri had to look toward the U.S., securing $1 million USD (approximately $1.4 million CAD) in pre-seed funding from Y Combinator and the U.S.-based deeptech VC firm Julian Capital. This capital allowed the team to secure lab space within the MaRS Discovery District and hire their first scientist.

Despite the American funding, Hassan remains committed to the local ecosystem. He told BetaKit that he is a proponent of building bio companies in Toronto to ensure a strong local ecosystem, citing the abundance of brilliant grad students and postdocs in the city.

As for the immediate roadmap, Molagri is focusing its initial "wedge product" on tree fruits and tree nuts due to an "acute insecticide need," which means much of their early operational focus will be in California. However, Hassan's long-term goal is to scale the company in Canada and eventually become a global provider. The founders will present their vision to investors during the Y Combinator Demo Day on Sept. 10, with plans to use a seed raise to build a "war chest" for hiring more scientists in Toronto.

Sources

More from Priya Raman